ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HRTX Heron Therapeautics Inc

3.45
0.225 (6.98%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Heron Therapeautics Inc HRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.225 6.98% 3.45 14:00:08
Open Price Low Price High Price Close Price Previous Close
3.22 3.22 3.515 3.42 3.225
more quote information »

Recent News

Date Time Source Heading
19/6/202406:43EDGAR2Form 8-K - Current report
18/6/202404:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202401:08EDGAR2Form SC 13D/A - General statement of acquisition of..
29/5/202422:05EDGAR2Form 8-K - Current report
29/5/202422:05PRNUSHeron Therapeutics Announces Prior Approval Supplement..
07/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:05EDGAR2Form 8-K - Current report
07/5/202422:00PRNUSHeron Therapeutics Announces First Quarter 2024 Financial..
24/4/202422:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
12/4/202406:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
29/3/202407:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
14/3/202407:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
13/3/202407:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
12/3/202422:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
29/2/202400:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
15/2/202408:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202408:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202401:25APSPremarket Heats Up For Biotech Before Opening Bell
25/1/202400:01EDGAR2Form 8-K - Current report
24/1/202412:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
20/1/202413:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202412:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202408:07EDGAR2Form 8-K - Current report
08/1/202409:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
23/12/202308:30EDGAR2Form 8-K - Current report
22/12/202309:25EDGAR2Form 8-K - Current report
07/12/202308:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/11/202304:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202304:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202304:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202304:25APSBiotech Shares Up Sharply Following Quarterly Results
15/11/202308:10EDGAR2Form 8-K - Current report
15/11/202308:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
08/11/202308:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
18/10/202310:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202306:08EDGAR2Form S-3 - Registration statement under Securities Act of..
15/8/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/8/202306:11EDGAR2Form 8-K - Current report
15/8/202306:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..